AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
59.70
+4.29 (7.74%)
At close: Mar 9, 2026, 4:00 PM EDT
60.58
+0.88 (1.47%)
After-hours: Mar 9, 2026, 7:34 PM EDT
AnaptysBio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 238.2 | 123.08 | 35.97 | 71.31 | 495.73 | Upgrade
|
| Short-Term Investments | 73.44 | 262.29 | 354.94 | 369.93 | 52.37 | Upgrade
|
| Cash & Short-Term Investments | 311.64 | 385.37 | 390.9 | 441.24 | 548.1 | Upgrade
|
| Cash Growth | -19.13% | -1.42% | -11.41% | -19.50% | 39.23% | Upgrade
|
| Accounts Receivable | 33.85 | 40.77 | 6.85 | 1.42 | 0.88 | Upgrade
|
| Receivables | 33.85 | 40.77 | 6.85 | 1.42 | 0.88 | Upgrade
|
| Prepaid Expenses | 4.76 | 5.74 | 9.08 | 4.55 | 4.9 | Upgrade
|
| Total Current Assets | 350.25 | 431.88 | 406.84 | 447.21 | 553.88 | Upgrade
|
| Property, Plant & Equipment | 13.89 | 16.23 | 18.27 | 19.99 | 21.84 | Upgrade
|
| Long-Term Investments | - | 35.47 | 27.03 | 142.94 | 67.1 | Upgrade
|
| Other Long-Term Assets | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | Upgrade
|
| Total Assets | 364.4 | 483.83 | 452.39 | 610.38 | 643.07 | Upgrade
|
| Accounts Payable | 3.87 | 4 | 4.7 | 2.78 | 1.74 | Upgrade
|
| Accrued Expenses | 32.29 | 39.5 | 30.51 | 21.63 | 12.85 | Upgrade
|
| Current Portion of Leases | 2.08 | 1.93 | 1.78 | 1.64 | 1.51 | Upgrade
|
| Other Current Liabilities | 0.38 | - | 0.46 | - | - | Upgrade
|
| Total Current Liabilities | 38.63 | 45.43 | 37.44 | 26.05 | 16.1 | Upgrade
|
| Long-Term Debt | 276.53 | 353.43 | 310.81 | 304.41 | 251.09 | Upgrade
|
| Long-Term Leases | 12.03 | 14.11 | 16.04 | 17.81 | 19.45 | Upgrade
|
| Total Liabilities | 327.19 | 412.97 | 364.29 | 348.28 | 286.64 | Upgrade
|
| Common Stock | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | Upgrade
|
| Additional Paid-In Capital | 809.77 | 829.86 | 702.97 | 717.8 | 678.58 | Upgrade
|
| Retained Earnings | -772.56 | -759.33 | -614.1 | -450.48 | -321.75 | Upgrade
|
| Comprehensive Income & Other | -0.02 | 0.31 | -0.8 | -5.25 | -0.42 | Upgrade
|
| Total Common Equity | 37.21 | 70.87 | 88.1 | 262.1 | 356.43 | Upgrade
|
| Shareholders' Equity | 37.21 | 70.87 | 88.1 | 262.1 | 356.43 | Upgrade
|
| Total Liabilities & Equity | 364.4 | 483.83 | 452.39 | 610.38 | 643.07 | Upgrade
|
| Total Debt | 290.64 | 369.46 | 328.62 | 323.86 | 272.05 | Upgrade
|
| Net Cash (Debt) | 21 | 15.91 | 62.28 | 117.38 | 276.05 | Upgrade
|
| Net Cash Growth | 31.98% | -74.45% | -46.94% | -57.48% | -29.81% | Upgrade
|
| Net Cash Per Share | 0.73 | 0.56 | 2.31 | 4.17 | 10.06 | Upgrade
|
| Filing Date Shares Outstanding | 28.75 | 30.67 | 26.76 | 27.93 | 27.67 | Upgrade
|
| Total Common Shares Outstanding | 28.02 | 30.47 | 26.6 | 28.51 | 27.65 | Upgrade
|
| Working Capital | 311.63 | 386.45 | 369.39 | 421.15 | 537.78 | Upgrade
|
| Book Value Per Share | 1.33 | 2.33 | 3.31 | 9.19 | 12.89 | Upgrade
|
| Tangible Book Value | 37.21 | 70.87 | 88.1 | 262.1 | 356.43 | Upgrade
|
| Tangible Book Value Per Share | 1.33 | 2.33 | 3.31 | 9.19 | 12.89 | Upgrade
|
| Machinery | 8.31 | 8.25 | 8.11 | 7.46 | 7 | Upgrade
|
| Leasehold Improvements | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.